Differentiating vasculitis from other diseases: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 14: | Line 14: | ||
! colspan="3" rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Diseases | ! colspan="3" rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Diseases | ||
| colspan="8" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Clinical manifestations''' | | colspan="8" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Clinical manifestations''' | ||
! colspan=" | ! colspan="8" rowspan="2" |Para-clinical findings | ||
| colspan="1" rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Gold standard''' | | colspan="1" rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Gold standard''' | ||
! rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings | ! rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings | ||
Line 22: | Line 22: | ||
|- | |- | ||
! colspan="4" |Lab Findings | ! colspan="4" |Lab Findings | ||
! colspan=" | ! colspan="4" style="background:#4479BA; color: #FFFFFF;" |Imaging | ||
|- | |- | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Headache | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Headache | ||
Line 36: | Line 36: | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |ESR | ! style="background:#4479BA; color: #FFFFFF;" align="center" |ESR | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Other | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Other | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |CT scan | ! style="background:#4479BA; color: #FFFFFF;" align="center" |CT scan | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Angiography | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Angiography | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Ultrasound | |||
!Other | |||
|- | |- | ||
! rowspan="9" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Large-Vessel Vasculitis | ! rowspan="9" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Large-Vessel Vasculitis | ||
! colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Takayasu arteritis]] | ! colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Takayasu arteritis]]<ref name="pmid23626437">{{cite journal| author=Vaideeswar P, Deshpande JR| title=Pathology of Takayasu arteritis: A brief review. | journal=Ann Pediatr Cardiol | year= 2013 | volume= 6 | issue= 1 | pages= 52-8 | pmid=23626437 | doi=10.4103/0974-2069.107235 | pmc=3634248 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23626437 }}</ref> | ||
! | !+ | ||
! | !+/- | ||
! | !+ | ||
! | !+ | ||
! | !+ | ||
! | !+ | ||
! | !+/- | ||
! | !+/- | ||
! | ![[ESR]] | ||
! | ![[Leukocytosis]], [[Anemia]] | ||
! | !↑ | ||
! | ![[CRP]] | ||
! | ![[Aneurysm|Aneurysmal dilatation]] of the [[aorta]] | ||
! | ![[Blood vessel]] [[stenosis]] | ||
! | !Circumferential thickening of the [[arterial]] wall (Macaroni sign) | ||
! | ![[PET scan|PET-scan]], [[Cardiac]] [[CT]] | ||
! | ![[Arteriography]] | ||
![[Coronary aneurysm]] | |||
|- | |- | ||
! colspan="2" |[[Giant cell arteritis]] | ! colspan="2" |[[Giant cell arteritis]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 79: | Line 82: | ||
! | ! | ||
|- | |- | ||
! rowspan="3" |Neurological disease | ! rowspan="3" |[[Neurological disease]] | ||
![[Cerebral aneurysm]] | ![[Cerebral aneurysm]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 100: | Line 104: | ||
|- | |- | ||
![[Neurofibromatosis type 1]] | ![[Neurofibromatosis type 1]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 119: | Line 124: | ||
|- | |- | ||
![[Neurofibromatosis type 2]] | ![[Neurofibromatosis type 2]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 137: | Line 143: | ||
! | ! | ||
|- | |- | ||
! rowspan="4" |Systemic disease | ! rowspan="4" |[[Systemic disease]] | ||
![[Fibromuscular dysplasia]] | ![[Fibromuscular dysplasia]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 158: | Line 165: | ||
|- | |- | ||
![[Ehlers-Danlos syndrome]] | ![[Ehlers-Danlos syndrome]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 177: | Line 185: | ||
|- | |- | ||
![[Polymyalgia rheumatica|Polymyalgia rheumatica (PMR)]] | ![[Polymyalgia rheumatica|Polymyalgia rheumatica (PMR)]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 196: | Line 205: | ||
|- | |- | ||
![[Amyloidosis]] | ![[Amyloidosis]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 216: | Line 226: | ||
! rowspan="18" |Medium-Vessel Vasculitis | ! rowspan="18" |Medium-Vessel Vasculitis | ||
! colspan="2" |[[Polyarteritis nodosa]] | ! colspan="2" |[[Polyarteritis nodosa]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 235: | Line 246: | ||
|- | |- | ||
! colspan="2" |[[Hepatitis B virus]]-associated [[polyarteritis nodosa]] | ! colspan="2" |[[Hepatitis B virus]]-associated [[polyarteritis nodosa]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 254: | Line 266: | ||
|- | |- | ||
! colspan="2" |[[Kawasaki disease]] | ! colspan="2" |[[Kawasaki disease]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 272: | Line 285: | ||
! | ! | ||
|- | |- | ||
! rowspan="10" |Infectious disease | ! rowspan="10" |[[Infectious disease]] | ||
!Parvovirus B19 infection | ![[Parvovirus B19 infection]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 292: | Line 306: | ||
! | ! | ||
|- | |- | ||
!Scarlet fever | ![[Scarlet fever]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 311: | Line 326: | ||
! | ! | ||
|- | |- | ||
!Toxic shock syndrome | ![[Toxic shock syndrome]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 330: | Line 346: | ||
! | ! | ||
|- | |- | ||
!Mononucleosis | ![[Mononucleosis]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 349: | Line 366: | ||
! | ! | ||
|- | |- | ||
!Leptospirosis | ![[Leptospirosis]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 368: | Line 386: | ||
! | ! | ||
|- | |- | ||
!Lyme Disease | ![[Lyme disease|Lyme Disease]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 387: | Line 406: | ||
! | ! | ||
|- | |- | ||
!Measles | ![[Measles]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 406: | Line 426: | ||
! | ! | ||
|- | |- | ||
! | ![[Rocky Mountain Spotted Fever]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 425: | Line 446: | ||
! | ! | ||
|- | |- | ||
!Staphylococcal Scalded Skin Syndrome | ![[Staphylococcal scalded skin syndrome|Staphylococcal Scalded Skin Syndrome]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 444: | Line 466: | ||
! | ! | ||
|- | |- | ||
!Toxic Epidermal Necrolysis | ![[Toxic Epidermal Necrolysis]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 463: | Line 486: | ||
! | ! | ||
|- | |- | ||
! rowspan="3" |Cardiovascular disease | ! rowspan="3" |[[Cardiovascular disease]] | ||
!Atrial Myxoma | ![[Atrial Myxoma]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 483: | Line 507: | ||
! | ! | ||
|- | |- | ||
!Cholesterol Embolism | ![[Cholesterol Embolism]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 502: | Line 527: | ||
! | ! | ||
|- | |- | ||
!Segmental arterial mediolysis | ![[Segmental arteries|Segmental arterial]] mediolysis | ||
! | |||
! | ! | ||
! | ! | ||
Line 521: | Line 547: | ||
! | ! | ||
|- | |- | ||
! rowspan="2" |Systemic disease | ! rowspan="2" |[[Systemic disease]] | ||
!Antiphospholipid Syndrome | ![[Antiphospholipid syndrome|Antiphospholipid Syndrome]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 541: | Line 568: | ||
! | ! | ||
|- | |- | ||
!Juvenile Idiopathic Arthritis | ![[Juvenile Idiopathic Arthritis]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 561: | Line 589: | ||
|- | |- | ||
! rowspan="33" |Small-Vessel Vasculitis | ! rowspan="33" |Small-Vessel Vasculitis | ||
! rowspan="4" |ANCA-associated vasculitis | ! rowspan="4" |[[ANCA-associated vasculitis]] | ||
![[Microscopic polyangiitis]] | ![[Microscopic polyangiitis]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 582: | Line 611: | ||
|- | |- | ||
![[Granulomatosis with polyangiitis|Granulomatosis with polyangiitis (Wegener’s)]] | ![[Granulomatosis with polyangiitis|Granulomatosis with polyangiitis (Wegener’s)]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 601: | Line 631: | ||
|- | |- | ||
![[Eosinophilic granulomatosis with polyangiitis|Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)]] | ![[Eosinophilic granulomatosis with polyangiitis|Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 620: | Line 651: | ||
|- | |- | ||
![[Hydralazine]]-associated [[ANCA-associated vasculitis]] | ![[Hydralazine]]-associated [[ANCA-associated vasculitis]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 638: | Line 670: | ||
! | ! | ||
|- | |- | ||
! rowspan="5" |Immune complex small-vessel vasculitis | ! rowspan="5" |[[Immune complexes|Immune complex]] small-vessel vasculitis | ||
![[Goodpasture disease|Anti-glomerular basement membrane disease]] | ![[Goodpasture disease|Anti-glomerular basement membrane disease]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 659: | Line 692: | ||
|- | |- | ||
![[Cryoglobulinemia|Cryoglobulinemic vasculitis]] | ![[Cryoglobulinemia|Cryoglobulinemic vasculitis]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 678: | Line 712: | ||
|- | |- | ||
! [[Hepatitis C virus]]-associated [[Cryoglobulinemia|cryoglobulinemic vasculitis]] | ! [[Hepatitis C virus]]-associated [[Cryoglobulinemia|cryoglobulinemic vasculitis]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 697: | Line 732: | ||
|- | |- | ||
![[Henoch-Schönlein purpura|IgA vasculitis (Henoch-Schönlein purpura)]] | ![[Henoch-Schönlein purpura|IgA vasculitis (Henoch-Schönlein purpura)]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 716: | Line 752: | ||
|- | |- | ||
![[Hypocomplementemia|Hypocomplementemic urticarial vasculitis (anti-C1q vasculitis)]] | ![[Hypocomplementemia|Hypocomplementemic urticarial vasculitis (anti-C1q vasculitis)]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 734: | Line 771: | ||
! | ! | ||
|- | |- | ||
!Gastrointestinal disease | ![[Gastrointestinal diseases|Gastrointestinal disease]] | ||
![[Acute mesenteric ischemia]] | ![[Acute mesenteric ischemia]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 754: | Line 792: | ||
! | ! | ||
|- | |- | ||
! rowspan="2" |Cardiovascular disease | ! rowspan="2" |[[Cardiovascular diseases|Cardiovascular disease]] | ||
!Infective Endocarditis | ![[Infective Endocarditis]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 774: | Line 813: | ||
! | ! | ||
|- | |- | ||
!Leukocytoclastic Vasculitis | ![[Leukocytoclastic vasculitis|Leukocytoclastic Vasculitis]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 793: | Line 833: | ||
! | ! | ||
|- | |- | ||
! rowspan="6" |Pulmonary disease | ! rowspan="6" |[[Pulmonary disease]] | ||
!Langerhans Cell Histiocytosis | ![[Langerhans Cell Histiocytosis]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 813: | Line 854: | ||
! | ! | ||
|- | |- | ||
!Lung Abscess | ![[Lung abscess|Lung Abscess]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 832: | Line 874: | ||
! | ! | ||
|- | |- | ||
!Non-Small Cell Lung Cancer | ![[Non small cell lung cancer|Non-Small Cell Lung Cancer]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 851: | Line 894: | ||
! | ! | ||
|- | |- | ||
!Small Cell Lung Cancer | ![[Small cell lung cancer|Small Cell Lung Cancer]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 870: | Line 914: | ||
! | ! | ||
|- | |- | ||
!Asthma | ![[Asthma]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 889: | Line 934: | ||
! | ! | ||
|- | |- | ||
!Pulmonary Infarction | ![[Pulmonary Infarction]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 908: | Line 954: | ||
! | ! | ||
|- | |- | ||
!Renal disease | ![[Renal disease]] | ||
!Acute Poststreptococcal Glomerulonephritis | ![[Acute poststreptococcal glomerulonephritis|Acute Poststreptococcal Glomerulonephritis]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 928: | Line 975: | ||
! | ! | ||
|- | |- | ||
! rowspan="9" |Hematologic disease | ! rowspan="9" |[[Hematologic disease]] | ||
!Hemolytic-Uremic Syndrome | ![[Hemolytic-uremic syndrome|Hemolytic-Uremic Syndrome]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 948: | Line 996: | ||
! | ! | ||
|- | |- | ||
!Chronic Lymphocytic Leukemia (CLL) | ![[Chronic Lymphocytic Leukemia|Chronic Lymphocytic Leukemia (CLL)]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 967: | Line 1,016: | ||
! | ! | ||
|- | |- | ||
!Multiple Myeloma | ![[Multiple myeloma|Multiple Myeloma]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 986: | Line 1,036: | ||
! | ! | ||
|- | |- | ||
!Hypereosinophilic Syndrome | ![[Hypereosinophilic syndrome|Hypereosinophilic Syndrome]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 1,005: | Line 1,056: | ||
! | ! | ||
|- | |- | ||
!Non-Hodgkin Lymphoma | ![[Non-Hodgkin lymphoma|Non-Hodgkin Lymphoma]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 1,024: | Line 1,076: | ||
! | ! | ||
|- | |- | ||
!Serum Sickness | ![[Serum sickness|Serum Sickness]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 1,043: | Line 1,096: | ||
! | ! | ||
|- | |- | ||
!Disseminated Intravascular Coagulation | ![[Disseminated intravascular coagulation|Disseminated Intravascular Coagulation]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 1,062: | Line 1,116: | ||
! | ! | ||
|- | |- | ||
!Idiopathic Thrombocytopenic Purpura | ![[Idiopathic thrombocytopenic purpura|Idiopathic Thrombocytopenic Purpura]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 1,082: | Line 1,137: | ||
|- | |- | ||
![[B cell lymphoproliferative disease|B cell lymphoproliferative disorder]] | ![[B cell lymphoproliferative disease|B cell lymphoproliferative disorder]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 1,100: | Line 1,156: | ||
! | ! | ||
|- | |- | ||
! rowspan="5" |Systemic disease | ! rowspan="5" |[[Systemic disease]] | ||
!Sarcoidosis | ![[Sarcoidosis]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 1,120: | Line 1,177: | ||
! | ! | ||
|- | |- | ||
!Legionella Infection | ![[Legionella Infections|Legionella Infection]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 1,140: | Line 1,198: | ||
|- | |- | ||
![[Systemic lupus erythematosus]] | ![[Systemic lupus erythematosus]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 1,159: | Line 1,218: | ||
|- | |- | ||
![[Rheumatoid arthritis]] | ![[Rheumatoid arthritis]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 1,178: | Line 1,238: | ||
|- | |- | ||
![[Relapsing polychondritis]] | ![[Relapsing polychondritis]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 1,198: | Line 1,259: | ||
! rowspan="5" |Variable-vessel vasculitis | ! rowspan="5" |Variable-vessel vasculitis | ||
! colspan="2" |[[Behçet's disease|Behçet’s syndrome]] | ! colspan="2" |[[Behçet's disease|Behçet’s syndrome]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 1,217: | Line 1,279: | ||
|- | |- | ||
! colspan="2" |[[Cogan syndrome|Cogan's syndrome]] | ! colspan="2" |[[Cogan syndrome|Cogan's syndrome]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 1,235: | Line 1,298: | ||
! | ! | ||
|- | |- | ||
! rowspan="3" |Gastrointestinal disease | ! rowspan="3" |[[Gastrointestinal diseases|Gastrointestinal disease]] | ||
!Inflammatory Bowel Disease | ![[Inflammatory bowel disease|Inflammatory Bowel Disease]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 1,255: | Line 1,319: | ||
! | ! | ||
|- | |- | ||
!Whipple's disease | ![[Whipple's disease]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 1,274: | Line 1,339: | ||
! | ! | ||
|- | |- | ||
!Sjögren's syndrome | ![[Sjögren's syndrome]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 1,295: | Line 1,361: | ||
! rowspan="6" |Single-organ vasculitis | ! rowspan="6" |Single-organ vasculitis | ||
! colspan="2" |Primary [[central nervous system]] [[vasculitis]] | ! colspan="2" |Primary [[central nervous system]] [[vasculitis]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 1,313: | Line 1,380: | ||
! | ! | ||
|- | |- | ||
! rowspan="3" |Infectious disease | ! rowspan="3" |[[Infectious disease]] | ||
!Aspergillosis | ![[Aspergillosis]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 1,333: | Line 1,401: | ||
! | ! | ||
|- | |- | ||
!Histoplasmosis | ![[Histoplasmosis]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 1,352: | Line 1,421: | ||
! | ! | ||
|- | |- | ||
!Herpes Simplex Encephalitis | ![[Herpes Simplex Encephalitis]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 1,371: | Line 1,441: | ||
! | ! | ||
|- | |- | ||
! rowspan="2" |Systemic disease | ! rowspan="2" |[[Systemic diseases|Systemic disease]] | ||
!Eclampsia | ![[Eclampsia]] | ||
! | |||
! | ! | ||
! | ! | ||
Line 1,391: | Line 1,462: | ||
! | ! | ||
|- | |- | ||
!Fibromuscular Dysplasia | ![[Fibromuscular dysplasia|Fibromuscular Dysplasia]] | ||
! | |||
! | ! | ||
! | ! |
Revision as of 13:51, 22 March 2018
Vasculitis |
|
---|
gsEditor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
Differential Diagnosis
Abbreviations: ABG= Arterial blood gas, ANP= Atrial natriuretic peptide, BNP= Brain natriuretic peptide, CBC= Complete blood count, COPD= Chronic obstructive pulmonary disease, CRP= C-reactive protein, CT= Computed tomography, CXR= Chest X-ray, DVT= Deep vein thrombosis, ESR= Erythrocyte sedimentation rate, HRCT= High Resolution CT, IgE= Immunoglobulin E, LDH= Lactate dehydrogenase, PCWP= Pulmonary capillary wedge pressure.
References
- ↑ Vaideeswar P, Deshpande JR (2013). "Pathology of Takayasu arteritis: A brief review". Ann Pediatr Cardiol. 6 (1): 52–8. doi:10.4103/0974-2069.107235. PMC 3634248. PMID 23626437.